Skip to content

Report: Revolutionizing pharmaceutical R&D: Harnessing AI to combat escalating costs

Pharmaceutical R&D is an exciting field but complex, expensive and uncertain. Researchers can spend years discovering, formulating and testing drugs and treatments, all without the certainty that the final product will gain approval and go to market. 

Fortunately, recent advances in artificial intelligence (AI) are helping researchers accelerate the drug discovery process, improve clinical trials and reduce costs.

This guide discusses how AI is supercharging pharmaceutical companies — and how you can leverage the power of AI to improve performance.

The latest Starmind research report, The High Cost of Inaccessible Knowledge, reveals the extent to which time is wasted and business opportunities are lost, as a result of inadequate and old-fashioned knowledge management practices.

For its research, conducted in July 2022, Starmind engaged with 1,400 respondents in the UK, the US, Switzerland and Germany. Each respondent is a full-time knowledge worker at a company with over 10,000 employees.

This executive summary captures key learnings from the survey, as they pertain to the UK market, and the ways in which business leaders can unlock multiple corporate benefits, ranging from increasing the time spent on the real tasks they need to complete, to more sales, and faster product and service evolution.

Click to access the UK Executive Summary



Sign up to receive latest stats, insights and events

Speak to an expert talk

We’re always ready to help, with support tailored to your business needs. Schedule a call with one of our team to:

  • Learn more about how Starmind can connect knowledge across your business.
  • Discover the use cases that best fit your needs.
  • See how you can bring all of your company’s knowledge into one central platform.
  • Discuss your bespoke pricing package.

Get in touch


How Secure AI Transforms the Flow of Work for Enterprise Organizations

Available on-demand

2023 is the beginning of the end for search. AI and machine learning are transforming the way we work. But with such rapid acceleration, how can you know that today’s models will provide secure, accurate information in the future? For enterprise organizations with extensive internal knowledge and experienced team members, this is an even greater challenge. 

Accessing company knowledge used to require burdensome documentation or searching endlessly for answers without any guarantee of success, even when using powerful search engines. Now, AI-powered tools such as GPT offer the potential for real-time answers to specific questions without having to sift through results. But while GPT focuses on static documented information, enterprises also need AI solutions that specialize in undocumented, dynamic information.

In this webinar with Starmind founder and CEO Marc Vontobel and Chief Customer Officer Ronan Kirby, they’ll discuss how secure AI will effortlessly connect your teams to the information they need and improve performance for the enterprise. You’ll come away with a better understanding of: 

  • What security and compliance features to look for when considering enterprise AI-based software.
  • What comes after GPT in integrating AI into the flow of work.
  • What GPT can and can’t do.
  • Why it’s more essential than ever that your IP is protected.

Watch today to learn how to review and compare AI options that make the most sense for your company.  


Fill in the form and watch free on-demand webinar


Revolutionizing pharmaceutical R&D:
Harnessing AI to combat escalating costs

In the pharmaceutical sector, R&D teams are constantly working to innovate while maximizing the value of their time and resources. The life-saving potential of new drugs and treatments is undeniable, but pharmaceutical companies face increasing costs and longer development cycle times. Every stage of R&D has experienced rising costs, from discovery through clinical trials to the market.

Fortunately, change is already in motion at leading pharma companies. AI and other disruptive technologies are helping R&D teams streamline and automate drug discovery efforts — and slash costs in the process. 

In this report we explore how pharma companies are leveraging the power of AI to combat escalating costs in R&D.

Download the report to take a deeper dive into:

  • The research cost conundrum and why it exists.
  • How AI is offsetting drug development costs.
  • The financial benefits of an AI-powered expertise directory in drug discovery.

Plus: Learn how Roche and Merck are using secure AI to transform how they work while reducing costs and fostering innovation.

Download the report today!

Resources |Blog post


Left side rich text

Right side rich text

Pillar section rich text